When most of us get breast cancer, we turn to the Internet 
and try to find information that will help us understand more about our breast cancer.
and try to find information that will help us understand more about our breast cancer. We aren’t just looking for information; we are looking for a host of things: reassurance, comfort, and how to get through treatment and get on with life. Surfing the net can be helpful if we are lucky enough to find reputable breast cancer sites and not sites that will only flame our fears about treatment or recurrences. But, even these sites may fall short of what we want and need. Many sites are written for large audiences and will not necessarily give us the answers to our specific breast cancer type, status, and treatment.
So, when I was invited to try out an online service that provides personalized information updates for people with serious medical conditions, such as breast cancer, I accepted. Now in its start up phase, Medivizor was founded by an interdisciplinary team of entrepreneurs with medical and information technology expertise.
Medivizor also asked me to extend an invitation to you, my readers, to experience their service and give feedback on the information you will receive via your email. You will not be inundated with materials, just a few articles every few days.
Ronen Keinan, Chief Operating Officer, describes the work of the new, free service as, “Medivizor provides personalized information updates including cutting edge research, new treatments, clinical trials and more, in a way that can be easily understood and acted upon. In other words, we help people get access to information that is relevant and specific to them by finding ‘the needle in the haystack’.
Often information found on the web is written for scientists and medical professionals, and is very difficult to understand for most people – even those well educated. It’s difficult to know what to trust and how to interpret the information. Much of the really promising and cutting edge research is published behind “pay walls”. Indeed, the most frustrating experience is when one develops a glimmer of hope that the new information in a research paper they read looks promising; they take it to their specialist and the doctor tells them it isn’t relevant because of some minute detail they couldn’t understand from the paper or about their condition. Medivizor aims to solve all that.
Once people sign up for Medivizor, they answer questions to describe themselves and their medical conditions. Medivizor then begins to provide them personalized information updates – suited just for them.
Medivizor is currently in invitation-only early access and supports a few medical conditions, such as breast cancer, prostate cancer, diabetes, and colorectal cancer. Soon we will add more conditions.
Anybody willing to check out our service (people either coping with or caring for others), and provide some feedback, can go to medivizor.com and sign up their interest or simply email us at [email protected], and we’ll invite them as soon as we can.”
